Ryan DeVitt

Director, Pricing & Contracting at Ionis Pharmaceuticals

Speaker

Ryan DeVitt is Director of Pricing & Contracting, US Market Access, at Ionis Pharmaceuticals, where he leads pricing strategy, payer and PBM/GPO contracting, and gross-to-net analytics for Ionis's rare disease portfolio. His current focus is rare disease launch contracting and access strategy in a consolidated PBM and GPO landscape.

He came to Ionis after more than a decade across Amgen, Takeda, and Nuvalent: at Amgen in payer pricing and contracting and oncology value and access; at Takeda leading US market access and channel strategy for Entyvio, including the Entyvio Pen launch, and for its rare GI portfolio; and at Nuvalent leading market access marketing for a precision oncology pipeline. A USC Marshall School of Business graduate, Ryan has seen firsthand what access to innovative medicines can mean for patients and families.